Medicinal chemistry – Page 31
-
ResearchSugars designed to disrupt bacterial cell wall biosynthesis
Rare monosaccharides explore concept for new narrow-spectrum antibiotics
-
WebinarRenewable resources: the future role of lignins
Learn how to gain more detailed insight into your lignin samples with Antje Potthast from Waters
-
ResearchSynthetic strategy exploits fluxional nitrogen to deliver three chiral centres for the price of one
Innovative method amplifies chirality and complexity in medicinally relevant cyclic hydrazines
-
ResearchE-liquids linked to US deaths form deadly compound when vaped
Pyrolysis of vitamin E acetate creates organic molecule with effects comparable to first world war chemical weapon
-
BusinessRevived Alzheimer’s antibody met with guarded optimism
Biogen’s aducanumab offers the possibility to slow disease progress, but regulators will likely want more convincing evidence
-
ResearchCompact pharmaceutical factory manufactures drugs on demand
Plant with modular design would occupy about half the area of a squash court
-
ResearchInorganic fragment library ready to help drug discoverers reach neglected regions of chemical space
A new approach to fragment-based drug design
-
NewsPoor antibiotic stewardship blamed as India found to be superbug’s birthplace
Spread of superbugs a growing problem for the subcontinent
-
ResearchTotal synthesis of H. pylori antigen creates starting point for gastric cancer vaccine
Remote participation strategy helps chemists make sterically-congested repeating fragment
-
FeatureCan smart biomaterials deliver?
James Mitchell Crow explores the next generation of therapeutic biomaterials, which aim to interact dynamically with the body and help to control diabetes and heal wounds
-
PodcastIminosugars
After some promising results treating ill pets, some researchers think iminosugars could become treatments for infection and even cancer. Mike Freemantle explores the buzz around iminohoney
-
BusinessPharmaceuticals roundup 2019
Under the shadow of political turmoil and major lawsuits, the industry returned to its strengths – making new drugs, and finding new ways to do it better
-
PodcastOxycodone and hydrocodone
Frances Addison examines how our quest to control and manage pain has led to a modern medical crisis, as opioids oxycodone and hydrocodone are among the most abused prescription medications in the US
-
ReviewSuperbugs: The Race to Stop an Epidemic
A doctor’s story about his fight against drug-resistant microbes that threaten the future of medicine
-
ResearchSpectroscopic biomarkers track Huntington’s disease progression
Analysis recognises biochemical changes that are unique to Huntington’s
-
ResearchEngineered insulin with enhanced thermal stability inspired by fish-hunting snails
Four-disulfide insulin has similar bioactivity to native human insulin
-
OpinionCleaning up chemical kitchens
In a busy plant, ensuring small changes don’t produce unforeseen toxic impurities is key
-
NewsEuropean commission gives green light to first Ebola vaccine
Drug shown to be effective and safe following clinical trials involving 16,000 people
-
ArticleArtificial intelligence: on the cusp of a digital revolution
AI is transforming the pharma industry and its drug discovery pipeline
-
ResearchFlow synthesis produces chiral intermediate for antidepressant drug
The first solvent-free organocatalytic flow process yields the key chiral intermediate for paroxetine on a multigram-scale